These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 10706554

  • 1. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
    Nagler A, Pines M, Abadi U, Pappo O, Zeira M, Rabbani E, Engelhardt D, Ohana M, Chowdhury NR, Chowdhury JR, Ilan Y.
    Hepatology; 2000 Mar; 31(3):641-8. PubMed ID: 10706554
    [Abstract] [Full Text] [Related]

  • 2. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y, Margalit M, Ohana M, Gotsman I, Rabbani E, Engelhardt D, Nagler A.
    Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461
    [Abstract] [Full Text] [Related]

  • 3. Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model.
    Ilan Y, Gotsman I, Pines M, Beinart R, Zeira M, Ohana M, Rabbani E, Engelhardt D, Nagler A.
    Blood; 2000 Jun 01; 95(11):3613-9. PubMed ID: 10828052
    [Abstract] [Full Text] [Related]

  • 4. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
    Nagler A, Ohana M, Alper R, Doviner V, Sherman Y, Rabbani E, Engelhardt D, Ilan Y.
    Bone Marrow Transplant; 2003 Aug 01; 32(4):363-9. PubMed ID: 12900772
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease.
    Howell CD, Yoder T, Claman HN, Vierling JM.
    J Immunol; 1989 Jul 15; 143(2):476-83. PubMed ID: 2472440
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
    Li S, Xu KL, Li ZY, Pan XY, Sun HY, Li DP, Cao J, Du B.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov 15; 28(11):727-30. PubMed ID: 18457261
    [Abstract] [Full Text] [Related]

  • 9. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY, Zhou WX, Zhang YX, Cheng JP, He JF, Yang RF, Yun LH.
    Life Sci; 2007 Oct 27; 81(19-20):1403-10. PubMed ID: 17950363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.
    Levi-Schaffer F, Goldenhersh MA, Segal V, Nagler A.
    Bone Marrow Transplant; 1997 Apr 27; 19(8):823-8. PubMed ID: 9134176
    [Abstract] [Full Text] [Related]

  • 13. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y.
    Cancer; 2002 Jan 15; 94(2):406-14. PubMed ID: 11900226
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F, Segal V, Barak V, Rubinchik E, Nagler A.
    Exp Hematol; 1997 Mar 15; 25(3):238-45. PubMed ID: 9091300
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity.
    Ilan Y, Ohana M, Pappo O, Margalit M, Lalazar G, Engelhardt D, Rabbani E, Nagler A.
    Transplantation; 2007 Feb 27; 83(4):458-67. PubMed ID: 17318079
    [Abstract] [Full Text] [Related]

  • 18. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
    Gotsman I, Shlomai A, Alper R, Rabbani E, Engelhardt D, Ilan Y.
    J Pharmacol Exp Ther; 2001 Jun 27; 297(3):926-32. PubMed ID: 11356912
    [Abstract] [Full Text] [Related]

  • 19. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model.
    Trop S, Samsonov D, Gotsman I, Alper R, Diment J, Ilan Y.
    Hepatology; 1999 Mar 27; 29(3):746-55. PubMed ID: 10051476
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.